Induced pluripotent stem cells for clinically applicable heart repair (iCARE) - preclinical evaluation in a non-human primate model and a roadmap for clinical application : Subproject1: Transplantation of genetically enriched human iPST (hiPSC) derived cardiomyocytes (CMs) in a preclinical model of heart repair in cynomolgus monkeys : final report for the federal funding program: "Innovative stem cell technologies in personalized medicine" - Martin, Ulrich (Mitwirkender); Haverich, Axel (Mitwirkender); Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (Herausgebendes Organ) (Fraunhofer Institut für Toxikologie und Experimentelle Medizin, 2022)